kabutan

Fuji Pharma, 18% Increase in Ordinary Profit, Record High for The First Time in Nine Years, Dividend Raised by 1.5 Yen

Tue Nov 11, 2025 4:30 pm JST Earnings

4554 Fuji Pharma Co.,Ltd. 【J-GAAP】

Earnings Report

Fuji Pharma Co.,Ltd. <4554> [TSE Prime] announced its financial results after the market closed on November 11th (16:30). The consolidated ordinary profit for the fiscal year ended September 2025 increased by 0.3% from the previous period to 4.45 billion yen. For the fiscal year ending September 2026, the consolidated ordinary profit is expected to grow by 17.5% to 5.24 billion yenExpected to reach record high profits for the first time in nine years. This will be the sixth consecutive term of revenue growth.

At the same time, the company has decided to increase the dividend this fiscal year to 47 yen, an increase of 1.5 yen from the previous fiscal year.

In the most recent three-month period, from July to September (4Q), the consolidated ordinary profit decreased to 1.30 billion yen, an 11.9% decrease compared to the same period last year. The operating profit margin decreased from 12.8% in the same period last year to 11.0%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2023 40,889 3,858 4,519 3,435 141.4 37 Nov 9, 2023 J-GAAP
Sep, 2024 46,138 3,880 4,445 6,146 252.9 42.50 Nov 12, 2024 J-GAAP
Sep, 2025 51,677 4,990 4,459 3,000 122.9 45.50 Nov 11, 2025 J-GAAP
YoY +12.0% +28.6% +0.3% -51.2% -51.4%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2025 Guidance 53,360 4,850 4,680 3,380 138.2 45.50 Nov 12, 2024 J-GAAP
Sep, 2025 Results 51,677 4,990 4,459 3,000 122.9 45.50 Nov 11, 2025 J-GAAP
Revision Rate -3.2% +2.9% -4.7% -11.2% -11.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 24,095 2,305 2,209 1,287 52.8 20 May 8, 2025 J-GAAP
Oct - Mar, 2025 Guidance 29,030 2,790 2,660 1,930 78.9 21 Nov 11, 2025 J-GAAP
YoY +20.5% +21.0% +20.4% +50.0% +49.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2024 46,138 3,880 4,445 6,146 252.9 42.50 Nov 12, 2024 J-GAAP
Sep, 2025 51,677 4,990 4,459 3,000 122.9 45.50 Nov 11, 2025 J-GAAP
Sep, 2026 Guidance 57,490 5,520 5,240 3,810 155.8 47 Nov 11, 2025 J-GAAP
YoY +11.2% +10.6% +17.5% +27.0% +26.7%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 12,983 1,665 1,478 1,236 50.9 12.8 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 13,000 1,252 1,376 991 40.8 9.6 Feb 6, 2025 J-GAAP
Jan - Mar, 2025 11,095 1,053 833 296 12.2 9.5 May 8, 2025 J-GAAP
Apr - Jun, 2025 12,859 1,062 948 543 22.3 8.3 Aug 7, 2025 J-GAAP
Jul - Sep, 2025 14,723 1,623 1,302 1,170 48.0 11.0 Nov 11, 2025 J-GAAP
YoY +13.4% -2.5% -11.9% -5.3% -5.7%

Related Articles